BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Lone Star Bio

  Premier Biomedical Research On Its Patent Pending Anti-Cancer Treatment With Metronomic Chemotherapy Recognized For Publication In The Prestigious British Journal Of Cancer

  December 6, 2016

   · 

  3 min read
• Drug Development

  AbbVie Release: New Phase 2 Data Show Nearly Half Of Patients With Relapsed/Refractory Marginal Zone Lymphoma (MZL) Respond To Treatment With Ibrutinib (IMBRUVICA)

  December 6, 2016

   · 

  11 min read
• Drug Development

  Eisai Inc. Announces Final Results From Phase 3 Open-Label Study Of Rufinamide At American Epilepsy Society Annual Meeting

  December 6, 2016

   · 

  5 min read
• Drug Development

  Janssen R&D Release: New Ibrutinib (IMBRUVICA) Phase 2 Data Demonstrate Promise In Relapsed/Refractory Marginal Zone Lymphoma (MZL), A Rare, Incurable Type Of Non-Hodgkin’s Lymphoma

  December 6, 2016

   · 

  11 min read
• Drug Development

  Janssen R&D Release: Daratumumab (DARZALEX) Combination Therapy Showed Consistent Clinical Benefit For Previously-Treated Patients With Multiple Myeloma

  December 6, 2016

   · 

  19 min read
• Neovasc Rockets on Early Data for Tiara Mitral Valve Implant

  December 6, 2016

   · 

  7 min read
• Business

  Abyrx Announces Expansion Of Exclusive, Worldwide License Agreement With Bezwada Biomedical; Completes $10M Equity Financing.

  December 6, 2016

   · 

  3 min read
• Business

  Peregrine To Report Financial Results For Second Quarter Of Fiscal Year 2017 After Market Close On December 12, 2016

  December 6, 2016

   · 

  1 min read
• Business

  BioQ Enters Into Strategic Partnership With Galen Limited To Commercialize Three Ready-To-Use Infusion Products In The United Kingdom And Ireland

  December 6, 2016

   · 

  1 min read
• Biotech Bay

  AcelRx Reports On ARX-04 Market And Landscape Presented At Analyst & Investor Event

  December 6, 2016

   · 

  6 min read